 Cellular Biomedicine Group Inc. Nasdaq: CBMG CBMG or the Company, a biopharmaceutical firm engaged in the drug development of immunotherapies for cancer and stem cell therapies for degenerative diseases, today announced the voting results of its 2020 Annual Meeting of Stockholders, held on June 26, 2020 in Long Island City, NY. Approximately 77 of the Companys outstanding shares were represented at the 2020 Annual Meeting. 